|
1
|
Jemal A, Siegel R, Ward E, Murray T, Xu J
and Thun MJ: Cancer statistics, 2007. CA Cancer J Clin. 57:43–66.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Ferlay J, Shin HR, Bray F, Forman D,
Mathers C and Parkin DM: Estimates of worldwide burden of cancer in
2008: GLOBOCAN 2008. Int J Cancer. 127:2893–2917. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Argiris A, Karamouzis MV, Raben D and
Ferris RL: Head and neck cancer. Lancet. 371:1695–1709. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Rusthoven K, Ballonoff A, Raben D and Chen
C: Poor prognosis in patients with stage I and II oral tongue
squamous cell carcinoma. Cancer. 112:345–351. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Brennan S, Corry J, Kleid S, Porceddu S,
Yuen K, Rischin D and Peters LJ: Prospective trial to evaluate
staged neck dissection or elective neck radiotherapy in patients
with CT-staged T1-2 N0 squamous cell carcinoma of the oral tongue.
Head Neck. 32:191–198. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Dean M, Fojo T and Bates S: Tumour stem
cells and drug resistance. Nat Rev Cancer. 5:275–284. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Zhang Q, Shi S, Yen Y, Brown J, Ta JQ and
Le AD: A subpopulation of CD133+ cancer stem-like cells
characterized in human oral squamous cell carcinoma confer
resistance to chemotherapy. Cancer Lett. 289:151–160. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Meroni G and Diez-Roux G: TRIM/RBCC, a
novel class of ‘single protein RING finger’ E3 ubiquitin ligases.
BioEssays. 27:1147–1157. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Su X, Wang J, Chen W, Li Z, Fu X and Yang
A: Overexpression of TRIM14 promotes tongue squamous cell carcinoma
aggressiveness by activating the NF-κB signaling pathway.
Oncotarget. 7:9939–9950. 2016.PubMed/NCBI
|
|
10
|
Bartel DP: MicroRNAs: Genomics,
biogenesis, mechanism, and function. Cell. 116:281–297. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Lee RC, Feinbaum RL and Ambros V: The
C. elegans heterochronic gene lin-4 encodes small
RNAs with antisense complementarity to lin-14. Cell.
75:843–854. 1993. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Pasquinelli AE, Reinhart BJ, Slack F,
Martindale MQ, Kuroda MI, Maller B, Hayward DC, Ball EE, Degnan B,
Müller P, et al: Conservation of the sequence and temporal
expression of let-7 heterochronic regulatory RNA. Nature.
408:86–89. 2000. View
Article : Google Scholar : PubMed/NCBI
|
|
13
|
Reinhart BJ, Slack FJ, Basson M,
Pasquinelli AE, Bettinger JC, Rougvie AE, Horvitz HR and Ruvkun G:
The 21-nucleotide let-7 RNA regulates developmental timing
in Caenorhabditis elegans. Nature. 403:901–906. 2000.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Lewis BP, Burge CB and Bartel DP:
Conserved seed pairing, often flanked by adenosines, indicates that
thousands of human genes are microRNA targets. Cell. 120:15–20.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Farh KK, Grimson A, Jan C, Lewis BP,
Johnston WK, Lim LP, Burge CB and Bartel DP: The widespread impact
of mammalian MicroRNAs on mRNA repression and evolution. Science.
310:1817–1821. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Duz MB, Karatas OF, Guzel E, Turgut NF,
Yilmaz M, Creighton CJ and Ozen M: Identification of miR-139-5p as
a saliva biomarker for tongue squamous cell carcinoma: A pilot
study. Cell Oncol. 39:187–193. 2016. View Article : Google Scholar
|
|
17
|
Kong D, Banerjee S, Ahmad A, Li Y, Wang Z,
Sethi S and Sarkar FH: Epithelial to mesenchymal transition is
mechanistically linked with stem cell signatures in prostate cancer
cells. PLoS One. 5:e124452010. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Ren ZG, Dong SX, Han P and Qi J: miR-203
promotes proliferation, migration and invasion by degrading SIK1 in
pancreatic cancer. Oncol Rep. 35:1365–1374. 2016.PubMed/NCBI
|
|
19
|
Park SY, Lee HE, Li H, Shipitsin M, Gelman
R and Polyak K: Heterogeneity for stem cell-related markers
according to tumor subtype and histologic stage in breast cancer.
Clin Cancer Res. 16:876–887. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Mansour SF and Atwa MM:
Clinicopathological significance of CD133 and ALDH1 cancer stem
cell marker expression in invasive ductal breast carcinoma. Asian
Pac J Cancer Prev. 16:7491–7496. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Tsai LL, Hu FW, Lee SS, Yu CH, Yu CC and
Chang YC: Oct4 mediates tumor initiating properties in oral
squamous cell carcinomas through the regulation of
epithelial-mesenchymal transition. PLoS One. 9:e872072014.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Chiou SH, Yu CC, Huang CY, Lin SC, Liu CJ,
Tsai TH, Chou SH, Chien CS, Ku HH and Lo JF: Positive correlations
of Oct-4 and Nanog in oral cancer stem-like cells and high-grade
oral squamous cell carcinoma. Cancer Res. 14:4085–4095. 2008.
|
|
23
|
Jun HJ, Ahn MJ, Kim HS, Yi SY, Han J, Lee
SK, Ahn YC, Jeong HS, Son YI, Baek JH, et al: ERCC1 expression as a
predictive marker of squamous cell carcinoma of the head and neck
treated with cisplatin-based concurrent chemoradiation. Br J
Cancer. 99:167–172. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Yoshikawa K, Noguchi K, Nakano Y, Yamamura
M, Takaoka K, Hashimoto-Tamaoki T and Kishimoto H: The Hippo
pathway transcriptional co-activator, YAP, confers resistance to
cisplatin in human oral squamous cell carcinoma. Int J Oncol.
46:2364–2370. 2015.PubMed/NCBI
|
|
25
|
Sun L, Yao Y, Liu B, Lin Z, Lin L, Yang M,
Zhang W, Chen W, Pan C, Liu Q, et al: MiR-200b and miR-15b regulate
chemotherapy-induced epithelial-mesenchymal transition in human
tongue cancer cells by targeting BMI1. Oncogene. 31:432–445. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Sanai N, Alvarez-Buylla A and Berger MS:
Neural stem cells and the origin of gliomas. N Engl J Med.
353:811–822. 2005. View Article : Google Scholar : PubMed/NCBI
|
